Veena Madappa will be representing Sai Life Sciences at the EFMC-ASMC 2025 (EFMC - European Federation for Medicinal Chemistry and Chemical Biology – Advances in Synthetic and Medicinal Chemistry). This symposium brings together chemists from around the world to explore the latest advances in synthetic chemistry, medicinal chemistry, chemical biology, and drug discovery. It provides a global platform for sharing strategies and methodologies shaping the future of innovation. For over 26 years, Sai Life Sciences has been a trusted partner in synthetic and medicinal chemistry. Our expertise spans a wide range of chemotypes and includes some of the most complex chemistries. Today, our focus on speed and innovation is helping advance therapies in small molecules, peptides, and drug conjugates. Connect with Veena at the Sai Life Sciences booth during EFMC–ASMC 2025 to explore how we can accelerate your discovery programs. #sailifesciences #medicinalchemistry #syntheticchemistry #chemistry #pharma #cro
Sai Life Sciences Ltd
Pharmaceutical Manufacturing
Gachibowli, Hyderabad, Telangana 173,577 followers
Full-service CRO-CDMO with a vision to propel the launch of 25 new medicines by 2025.
About us
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.
- Website
-
http://www.sailife.com
External link for Sai Life Sciences Ltd
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Gachibowli, Hyderabad, Telangana
- Type
- Privately Held
- Founded
- 1999
- Specialties
- Contract Research Organization, Contract Manufacturing Organization, Discovery Chemistry, Discovery Biology, Discovery Biology, Drug Development, Drug Manufacturing, Integrated Drug Discovery, Formulations Development, and Chemical Development
Locations
Employees at Sai Life Sciences Ltd
Updates
-
We have completed Phase II of Production Block 11 (PB-11) at our flagship API manufacturing facility in Bidar, India. With this addition of ~91 KL, PB-11 now stands at ~200 KL, making it the single largest reactor block at the site and taking the overall installed capacity to ~700 KL. For us, this expansion is more than numbers. It is about giving our partners confidence that we can scale with their programs, deliver reliably, and adapt to the increasing complexity of their needs. By strengthening our large-scale API and intermediate manufacturing, we aim to help clients move faster, de-risk supply chains, and bring new medicines to patients with greater assurance. You can read the full announcement here: https://lnkd.in/gRvmRTAk #sailifesciences #makeitbettertogether #drugdevelopment #cdmo #pharma #lifesciences #manufacturing #pharmamanufacturing
-
-
Join Jordan Oskowsky and Courtney Ober at ChemOutsourcing to explore how our deep CMC expertise, speed, and regulatory strength can help take your programs from development to commercial supply. Why meet us? ▪️ Scientific depth to solve complex challenges ▪️ Speed and reliability at every stage ▪️ 26+ years advancing pharma innovation ▪️ Trusted by 300+ global innovators ▪️ Partner to 18 of the top 25 big pharma companies Let’s connect at ChemOutsourcing and explore how we can move your programs forward. #sailifesciences #makeitbettertogether #pharma #cdmo #chemistry #cmc #drugmanufacturing #api
-
-
#AtoZofSai V – Values Rooted in what matters. At Sai Life Sciences, our values guide us every day—in the way we work, collaborate, and build lasting partnerships with clients and communities alike. Here are our values: ▪️Integrity: Doing what is fundamentally right. ▪️Respect: Treating people as we would like to be treated. ▪️Transparency: Having the confidence to share full knowledge of a problem openly. ▪️Collaboration: Delivering as a team. ▪️Ownership: Taking pride in our contribution to a project, while performing as an owner ▪️Reliability: Demonstrating consistent behaviour and striving to fulfil our commitment each time. Grounded in these values, we build science—and partnerships—you can count on. To know more, write to contact@sailife.com #sailifesciences #cro #cdmo #values #culture #pharma
-
Every year, the Hyderabad Marathon sees a growing tribe of Saimers hitting the track. This time, we had over 350 colleagues swapping lab coats for running gear, with participation rising steadily year after year. What’s most inspiring is the surge in women runners and the growing enthusiasm among our scientists, who bring the same passion to the marathon as they do to their work in the lab. With preparations starting nearly two months in advance, the Hyderabad Marathon has grown into more than just a race—it is now an annual ritual of energy, camaraderie, and shared spirit that everyone looks forward to. For us, it’s not just about running. It’s about pushing limits, celebrating togetherness, and moving forward. A special shout out to Tarun Sharma Ph.D Sharma who completed the full marathon and @Venkateswarlu Anipireddy and Harish Gollapally who ran half marathon. Sharing glimpses from this morning’s run. #hyderabadmarathon #makeitbettertogether #running #employeeengagement #pharma #cro #cdmo
-
-
-
-
-
+5
-
-
We are delighted to inform that Sai Life Sciences Limited’s near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. In June 2023, the company joined SBTi and committed to setting company-wide near-term GHG reduction targets. Sai Life Sciences Limited has committed to reduce absolute scope 1 and 2 GHG emissions 58.8% by FY2035 from a FY2024 base year.* Sai Life Sciences Limited also has committed to reduce scope 3 GHG emissions from purchased goods and services, capital goods, fuel- and energy-related activities, upstream transportation and distribution, business travel, and employee commuting 63.8% per INR value added within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks. #sailifesciences #sustainability #sdgs #ghg #makeitbettertogether
-
-
Sai Life Sciences was recently featured in Drug Discovery & Development, where Dr Maneesh Pingle, Executive Vice President and Head of Discovery Services, shared insights on the emerging trends in pharma sector. A key focus was the impact of GLP‑1 agonists in accelerating peptide drug discovery. Dr. Pingle explained how the success of these therapies has intensified demand for complex peptide design, synthesis, and conjugation capabilities. He emphasized the increasing preference among innovator companies for integrated discovery and development partners. Rather than managing multiple vendors, these companies are seeking single partners who can handle programs end-to-end—from early-stage design through development-ready candidates. Read the full article here: https://lnkd.in/gXPK5G_m #sailifesciences #crdmo #cro #cdmo #peptide #ADCs #GLP-1 #makeitbettertogether #pharma Brian K. Buntz
-
-
Courtney Ober will be representing Sai Life Sciences at the 'PDA - Parenteral Drug Association Southeast Chapter: Vendor Showcase – Pharma on the Right Track' on August 20. At Sai Life Sciences, we partner with 300+ global pharma and biotech innovators to accelerate NCE small molecule programs—from discovery to commercialization—helping bring impactful therapies to life, faster. Want to learn more about how we can support your next program? Meet Courtney at the event! #sailifesciences #cdmo #drugdevelopment #pharma #lifesciences #smallmolecules #makeitbettertogether
-
-
#AtoZofSai U – UN SDGs Committed to a Sustainable Future Sustainability is a core driver of how we operate, deliver and grow. Aligned with the UN Sustainable Development Goals, we’ve set ambitious targets through FY27: 🚰 Reduce specific water consumption by 25%. 🌅 Reduce specific greenhouse gas emissions by 30% and replace 70% of our energy requirement with renewable sources. 🚮 Reduce specific hazardous waste generation by 10% and recycle 90% of hazardous waste through co-processing and alternate reuse. 👩👧 Create more opportunities for women and increase the percentage of women employees in the total workforce to 18%. 👍 Advance socio-economic empowerment of women and provide education for 8,000 people from socially and less privileged communities through our CSR programs. 👨💼 Engage with 100% of critical suppliers in committing to the code of supplier conduct and ethics. Because building the medicines of tomorrow means taking responsibility today. Let’s make science more sustainable—together. Write to: contact@sailife.com #sailifesciences #unsdg #sdg #sustainability #water #renewableenergy #green #pharma
-
#AtoZofSai T – Trust Earned, Every Single Day At Sai Life Sciences, trust is built not just on what we deliver—but how we communicate along the way. We're transparent in our approach, proactive in our updates, and honest when things get complex. Add to that our commitment to confidentiality and scientific integrity—and you have a partner who safeguards your program as if it were their own. Because in drug development, trust isn’t a promise—it’s a daily practice. Let’s build something that lasts. Write to: contact@sailife.com #sailifesciences #cro #cdmo #pharma #lifesciences #trust #culture #values #makeitbettertogether